Randomized controlled trial to compare the efficacy and safety of oral paricalcitol with oral calcitriol in dialysis patients with secondary hyperparathyroidism

Ong LM; Narayanan P; Goh HK; Manocha AB; Ghazali A; Omar M; Mohamad S; Goh BL; Shah S; Seman MR; Vaithilingam I; Ghazalli R; Rahmat K; Shaariah W; Ching CH; Oral Paricalcitol in ESRD Study Group

doi:10.1111/nep.12029

Randomized controlled trial to compare the efficacy and safety of oral paricalcitol with oral calcitriol in dialysis patients with secondary hyperparathyroidism

Ong LM , Narayanan P , Goh HK , Manocha AB , Ghazali A , Omar M Show all authors , Mohamad S , Goh BL , Shah S , Seman MR , Vaithilingam I , Ghazalli R , Rahmat K , Shaariah W , Ching CH , Oral Paricalcitol in ESRD Study Group

Nephrology (Carlton), 2013 Mar;18(3):194-200.

PMID: 23311404 DOI: 10.1111/nep.12029

Abstract

The objective of the study was to compare the efficacy and safety of oral paricalcitol with oral calcitriol for treating secondary hyperparathyroidism.

* Title and MeSH Headings from MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.